375 related articles for article (PubMed ID: 28986258)
1. Fractalkine/CX3CR1 axis modulated the development of pancreatic ductal adenocarcinoma via JAK/STAT signaling pathway.
Huang L; Ma B; Ma J; Wang F
Biochem Biophys Res Commun; 2017 Dec; 493(4):1510-1517. PubMed ID: 28986258
[TBL] [Abstract][Full Text] [Related]
2. Fractalkine upregulates inflammation through CX3CR1 and the Jak-Stat pathway in severe acute pancreatitis rat model.
Huang LY; Chen P; Xu LX; Zhou YF; Zhang YP; Yuan YZ
Inflammation; 2012 Jun; 35(3):1023-30. PubMed ID: 22213034
[TBL] [Abstract][Full Text] [Related]
3. Fractalkine upregulates intercellular adhesion molecule-1 in endothelial cells through CX3CR1 and the Jak Stat5 pathway.
Yang XP; Mattagajasingh S; Su S; Chen G; Cai Z; Fox-Talbot K; Irani K; Becker LC
Circ Res; 2007 Nov; 101(10):1001-8. PubMed ID: 17885215
[TBL] [Abstract][Full Text] [Related]
4. Early expression of the fractalkine receptor CX3CR1 in pancreatic carcinogenesis.
Celesti G; Di Caro G; Bianchi P; Grizzi F; Marchesi F; Basso G; Rahal D; Delconte G; Catalano M; Cappello P; Roncalli M; Zerbi A; Montorsi M; Novelli F; Mantovani A; Allavena P; Malesci A; Laghi L
Br J Cancer; 2013 Oct; 109(9):2424-33. PubMed ID: 24084767
[TBL] [Abstract][Full Text] [Related]
5. Fractalkine promotes chemotaxis of bone marrow-derived mesenchymal stem cells towards ischemic brain lesions through Jak2 signaling and cytoskeletal reorganization.
Zhang Y; Zheng J; Zhou Z; Zhou H; Wang Y; Gong Z; Zhu J
FEBS J; 2015 Mar; 282(5):891-903. PubMed ID: 25559502
[TBL] [Abstract][Full Text] [Related]
6. Fractalkine/CX3CR1 induces apoptosis resistance and proliferation through the activation of the AKT/NF-κB cascade in pancreatic cancer cells.
Wang H; Cai J; Du S; Guo Z; Xin B; Wang J; Wei W; Shen X
Cell Biochem Funct; 2017 Aug; 35(6):315-326. PubMed ID: 28845524
[TBL] [Abstract][Full Text] [Related]
7. Fractalkine and its receptor mediate extracellular matrix accumulation in diabetic nephropathy in mice.
Song KH; Park J; Park JH; Natarajan R; Ha H
Diabetologia; 2013 Jul; 56(7):1661-9. PubMed ID: 23604552
[TBL] [Abstract][Full Text] [Related]
8. High expression of CX3CL1/CX3CR1 axis predicts a poor prognosis of pancreatic ductal adenocarcinoma.
Xu X; Wang Y; Chen J; Ma H; Shao Z; Chen H; Jin G
J Gastrointest Surg; 2012 Aug; 16(8):1493-8. PubMed ID: 22639377
[TBL] [Abstract][Full Text] [Related]
9. Expression of CX3CR1 associates with cellular migration, metastasis, and prognosis in human clear cell renal cell carcinoma.
Yao X; Qi L; Chen X; Du J; Zhang Z; Liu S
Urol Oncol; 2014 Feb; 32(2):162-70. PubMed ID: 23570708
[TBL] [Abstract][Full Text] [Related]
10. Activation of fractalkine/CX3CR1 by vascular endothelial cells induces angiogenesis through VEGF-A/KDR and reverses hindlimb ischaemia.
Ryu J; Lee CW; Hong KH; Shin JA; Lim SH; Park CS; Shim J; Nam KB; Choi KJ; Kim YH; Han KH
Cardiovasc Res; 2008 May; 78(2):333-40. PubMed ID: 18006432
[TBL] [Abstract][Full Text] [Related]
11. Diet-Induced Obesity Promotes Liver Metastasis of Pancreatic Ductal Adenocarcinoma via CX3CL1/CX3CR1 Axis.
Sun Y; Zhang XX; Huang S; Pan H; Gai YZ; Zhou YQ; Zhu L; Nie HZ; Li DX
J Immunol Res; 2022; 2022():5665964. PubMed ID: 35478937
[TBL] [Abstract][Full Text] [Related]
12. Up-regulated fractalkine (FKN) and its receptor CX3CR1 are involved in fructose-induced neuroinflammation: Suppression by curcumin.
Xu MX; Yu R; Shao LF; Zhang YX; Ge CX; Liu XM; Wu WY; Li JM; Kong LD
Brain Behav Immun; 2016 Nov; 58():69-81. PubMed ID: 26765996
[TBL] [Abstract][Full Text] [Related]
13. The chemokine fractalkine can activate integrins without CX3CR1 through direct binding to a ligand-binding site distinct from the classical RGD-binding site.
Fujita M; Takada YK; Takada Y
PLoS One; 2014; 9(5):e96372. PubMed ID: 24789099
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of CX
Stout MC; Narayan S; Pillet ES; Salvino JM; Campbell PM
Biochem Biophys Res Commun; 2018 Jan; 495(3):2264-2269. PubMed ID: 29274778
[TBL] [Abstract][Full Text] [Related]
15. Fractalkine stimulates cell growth and increases its expression via NF-κB pathway in RA-FLS.
Guo X; Pan Y; Xiao C; Wu Y; Cai D; Gu J
Int J Rheum Dis; 2012 Jun; 15(3):322-9. PubMed ID: 22709495
[TBL] [Abstract][Full Text] [Related]
16. Fractalkine is expressed in early and advanced atherosclerotic lesions and supports monocyte recruitment via CX3CR1.
Stolla M; Pelisek J; von Brühl ML; Schäfer A; Barocke V; Heider P; Lorenz M; Tirniceriu A; Steinhart A; Bauersachs J; Bray PF; Massberg S; Schulz C
PLoS One; 2012; 7(8):e43572. PubMed ID: 22916279
[TBL] [Abstract][Full Text] [Related]
17. CX3CL1 (Fractalkine)-CX3CR1 Axis in Inflammation-Induced Angiogenesis and Tumorigenesis.
Szukiewicz D
Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731899
[TBL] [Abstract][Full Text] [Related]
18. Expression of DRD2 Is Increased in Human Pancreatic Ductal Adenocarcinoma and Inhibitors Slow Tumor Growth in Mice.
Jandaghi P; Najafabadi HS; Bauer AS; Papadakis AI; Fassan M; Hall A; Monast A; von Knebel Doeberitz M; Neoptolemos JP; Costello E; Greenhalf W; Scarpa A; Sipos B; Auld D; Lathrop M; Park M; Büchler MW; Strobel O; Hackert T; Giese NA; Zogopoulos G; Sangwan V; Huang S; Riazalhosseini Y; Hoheisel JD
Gastroenterology; 2016 Dec; 151(6):1218-1231. PubMed ID: 27578530
[TBL] [Abstract][Full Text] [Related]
19. Inflammatory effects of resistin on human smooth muscle cells: up-regulation of fractalkine and its receptor, CX3CR1 expression by TLR4 and Gi-protein pathways.
Gan AM; Butoi ED; Manea A; Simion V; Stan D; Parvulescu MM; Calin M; Manduteanu I; Simionescu M
Cell Tissue Res; 2013 Jan; 351(1):161-74. PubMed ID: 23086480
[TBL] [Abstract][Full Text] [Related]
20. Fractalkine/CX3CR1 signalling in chronic pain and inflammation.
Clark AK; Staniland AA; Malcangio M
Curr Pharm Biotechnol; 2011 Oct; 12(10):1707-14. PubMed ID: 21466443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
